Lyell Immunopharma, Inc. · NASDAQ:LYEL
Seely Lynn sold 388 Lyell Immunopharma, Inc. shares (Form 4)
Traded May 11, 2026 · Filed Jun 15, 2026
On May 11, 2026, Seely Lynn (Director, President and CEO) sold 388 Lyell Immunopharma, Inc. shares at US$18.91 for US$7,337, leaving 73,878 shares. Filed Jun 15, 2026 (Form 4).
- Sold
- 388 shares
- Price
- US$18.91
- Value
- US$7,337
- Holding after
- 73,878 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 388 | US$18.91 | 73,878 | Direct |
Source
Related
- Lyell Immunopharma, Inc.
- Seely Lynn
- Lyell Immunopharma, Inc. shareholders
- Form 4 · Seely Lynn · Aug 25, 2026
- Form 4 · Seely Lynn · Aug 11, 2026
- Form 4 · Aguirre Jarrad Mattieu · Oct 13, 2026
- Form 4 · Shook David · Sep 10, 2026
- Form 4 · Hill Stephen J. · Aug 25, 2026
- Form 4 · Lee Gary K. · Aug 25, 2026
- Schedule 13G/A · James B. Tananbaum · Aug 14, 2026